Organic & Biomolecular Chemistry
Paper
1
Compound 13a(a): H NMR (400 MHz, D2O) δ 3.10 (dd, J = (1.5 mL). A quantitative mixture of compounds 13c : 8c in a
19.2, 2.0 Hz, 1H, H-3), 3.30 (dd, J = 19.2, 8.4 Hz, 1H, H-3), 3.78 2 : 1 ratio. Compound 13c was identified by 1H NMR
(dd, J = 12.4, 2.0 Hz, 1H, H-7), 3.90 (dd, J = 12.4, 3.6 Hz, 1H, H- (400 MHz, D2O) δ 2.91 (dd, J = 19.2, 2.0 Hz, 1H, H-3), 3.12 (dd,
7), 4.17 (d, J = 13.2 Hz, 1H, H-1′), 4.32–4.36 (m, 2H, H-3a + H- J = 19.2, 8.0 Hz, 1H, H-3), 3.59 (dd, J = 12.4, 2.0 Hz, 1H, H-7),
6), 4.44 (d, J = 13.2 Hz, 1H, H-1′), 4.87 (dd J = 5.6, 4.4 Hz, 1H, 3.70 (dd, J = 12.4, 3.2 Hz, 1H, H-7), 3.99 (d, J = 13.6 Hz, 1H, H-
H-6a), 7.44–7.51 (m, 10H, H–Ph) ppm; 13C NMR (100 MHz, 1′), 4.10 (d, J = 13.2 Hz, 1H, H-1′), 4.23–4.27 (m, 2H, H-3a + H-
D2O) δ 31.5 (C-3), 49.2 (C-1′), 55.6 (C-3a), 61.1 (C-7), 68.1 (C-6), 6), 4.77 (dd, J = 6.0, 4.4 Hz, 1H, H-6a), 7.01–7.05 (t, 2H, H-4′ +
80.8 (C-6a), 128.9 (C-2), 129.0 (C-3′ or C-4′ or C-5′), 129.3 (C-3′ H-6′), 7.28–7.31 (m, 2H, H-3′ + H-7′).
or C-4′ or C-5′), 129.5 (C-3′ or C-4′ or C-5′), 175.3 (CvO) ppm.
(ii) To a mixture obtained in step (i) (43 mg) was added
(a) The 1H NMR and 13C NMR descriptions were taken from water (2.5 mL) and solid KOH (23 mg, 0.14 mmol). Product 8c:
24
the crude material of the reaction of compound 6a with TFA, (20 mg, 0.074 mmol); η = 48%; [α]D = −23.0 (c 0.6, MeOH); IR
where a 3 : 1 ratio of compounds 13a (3) : 8a (1) was isolated.
1
(nujol) νmax 3347, 2926, 2856, 1660 cm−1; H NMR (400 MHz,
(ii) To the mixture obtained in step (i) (72.6 mg) was added D2O) δ 2.55 (dd, J = 14.8 Hz, 6.8 Hz, 1H, CH2CO2H), 2.60 (dd, J =
water (3.0 mL) and solid KOH (30 mg, 0.18 mmol). Product 8a: 14.8 Hz, 6.4 Hz, 1H, CH2CO2H), 3.27 (td, J = 6.8 Hz, 2.8 Hz, 1H,
24
(70 mg, 0.26 mmol); η = 96.3%; [α]D = −20.5 (c 0.4, MeOH); H-2), 3.50 (dd, J = 12.0 Hz, 6.0 Hz, 1H, H-5), 3.67 (dd, J = 12.0 Hz,
IR (nujol) νmax 3187, 1680 cm−1 1H NMR (400 MHz, D2O) δ 4.8 Hz, 1H, H-5), 3.73 (dd, J = 6.0, 2.8 Hz, 1H, H-3), 3.76–3.80 (m,
;
2.89 (dd, J = 18.0, 6.0 Hz, 1H, CH2CO2H), 3.95 (dd, J = 18.0, 6.4 1H, H-4), 3.79 (d, J = 12.8 Hz, 1H, H-1′), 3.96 (d, J = 13.2 Hz, 1H,
Hz, 1H, CH2CO2H), 3.51 (dd, J = 12.0, 6.4 Hz, 1H, H-5), 3.65 H-1′), 7.13–7.18 (m, 2H, H–Ph), 7.39–7.43 (m, 2H, H–Ph); 13C
(dd, J = 12.0, 4.0 Hz, 1H, H-5), 3.80 (td, J = 6.8, 3.2 Hz, 1H, H- NMR (100 MHz, D2O) δ 38.5 (CH2CO2H), 49.5 (C-1′), 55.7 (C-2),
2), 3.86 (td, J = 5.6, 4.0 Hz, 1H, H-4), 3.91 (dd, J = 5.6, 3.2 Hz, 62.3 (C-5), 71.5 (C-3), 73.4 (C-4), 115.2 (d, J = 22.0 Hz, C-4′ or
1H, H-3), 4.32 (d, J = 13.2 Hz, 1H, H-1′), 4.46 (d, J = 13.2 Hz, C-6′), 115.4 (d, J = 22.0 Hz, C-4′ or C-6′), 130.5 (d, J = 8.0 Hz, C-3′
1H, H-1′), 7.54 (s, 5H, H–Ph) ppm; 13C NMR (100 MHz, D2O) δ or C-7′), 130.6 (d, J = 8.0 Hz, C-3′ or C-7′), 134.2 (C-2′), 161.9 (d, J
30.2 (CH2CO2H), 46.4 (C-1′), 52.9 (C-2), 59.3 (C-5), 66.0 (C-3),
70.3 (C-4), 126.6 (C-3′ or C-4′ or C-5′), 127.1 (C-3′ or C-4′ or C13H19FNO5: 288.1242 (M + H2O + H+); found: 288.1242.
C-5′), 127.2 (C-3′ or C-4′ or C-5′), 127.8 (C-2′), 172.2 (CvO) 5.1.5. Synthesis 2-((2S,3S,4R)-N-(4-chlorobenzyl)-3,4-dihy-
ppm; elemental analysis, calcd for C13H17NO4: C, 62.14; H, droxypyrrolidin-2-yl)acetic acid (8d). (i) β-Aminoester 6d
6.82; N, 5.57. Found C, 62.20; H, 6.65; N, 5.76. (111 mg, 0.27 mmol); solvent: 1,4-dioxane (4 mL); HCl 37%
= 241.0 Hz, C-5′), 180.3 (CvO). HRMS (ESI): calcd for
5.1.3. Synthesis of 2-((2S,3S,4R)-N-piperonyl-3,4-dihydroxy- (2.8 mL). A quantitative mixture of compounds 13d : 8d in a
pyrrolidin-2-yl)acetic acid (8b). (i) β-Aminoester 6b (100 mg, 2 : 1 ratio. Compound 13d was identified by 1H NMR
0.24 mmol); 1,4-dioxane (3 mL); HCl 37% (2.5 mL). A quanti- (400 MHz, D2O) δ 3.02 (dd, J = 19.2, 2.0 Hz, 1H, H-3), 3.23 (dd, J
tative mixture of compounds 13b : 8b in a 2 : 1 ratio.
= 19.2, 8 Hz, 1H, H-3), 3.70 (dd, J = 12.4, 2.0 Hz, 1H, H-7), 3.83
1
Compound 13b was identified by H NMR (400 MHz, D2O) (dd, J = 12.4, 3.6 Hz, 1H, H-7), 4.09 (d, J = 13.2 Hz, 1H, H-1′),
δ 3.00 (dd, J = 18.8, 1.6 Hz, 1H, H-3), 3.23 (dd, J = 18.8, 8.0 Hz, 4.22–4.29 (m, 2H, H-3a + H-6), 4.35 (d, J = 13.2 Hz, 1H, H-1′),
1H, H-3), 3.72 (dd, J = 12.4, 2.0 Hz, 1H, H-7), 3.84 (dd, J = 12.0, 4.80 (dd, J = 6.0, 4.8 Hz, 1H, H-6a), 7.34–7.45 (m, 4H, H–Ph).
3.2 Hz, 1H, H-7), 4.03 (d, J = 13.2 Hz, 1H, H-1′), 4.14 (d, J = 13.6
(ii) To the mixture obtained in step (i) (83 mg) in water
Hz, 1H, H-1′), 4.25–4.31 (m, 2H, H-3a + H-6), 4.67 (dd, J = 5.6 (3.3 mL) was added solid KOH (33 mg, 0.20 mmol). Product
24
Hz, 4.8 Hz, 1H, H-6a), 5.95 (s, 2H, H-8′)(a), 6.88–6.94 (m, 3H, 8d: (66 mg; 0.23 mmol); η = 85.0%; [α]D = + 6.0 (c 0.7,
1
H–Ph)(a)
.
MeOH); IR (nujol) νmax 3346, 1690 cm−1; H NMR (400 MHz,
(a) These signals are coincident in the 1H NMR spectrum of D2O) δ 2.64 (dd, J = 16.4 Hz, 6.8 Hz, 1H, CH2CO2H), 2.70 (dd, J
the mixture of the two compounds 13b and 8b. = 16.4 Hz, 6.4 Hz, 1H, CH2CO2H), 3.52 (dd, J = 11.6 Hz, 5.6 Hz,
(ii) To a mixture obtained in step (i) (78 mg) was added 1H, H-5), 3.60 (td, J = 6.4 Hz, 3.2 Hz, 1H, H-2), 3.67 (dd, J =
water (3.0 mL) and solid KOH (30 mg, 0.18 mmol). Product 8b: 12.8 Hz, 4.4 Hz, 1H, H-5), 3.80–3.87 (m, 2H, H-3 + H-4), 4.16 (d,
24
(56 mg, 0.19 mmol); η = 79%; [α]D = −25.0 (c 0.6, MeOH); IR J = 13.2 Hz, 1H, H-1′), 4.28 (d, J = 13.2 Hz, 1H, H-1′), 7.44 (d, J =
(nujol) νmax 3350, 1586 cm−1 1H NMR (400 MHz, D2O) 8.4 Hz, 2H, H–Ph), 7.48 (d, J = 8.4 Hz, 2H, H–Ph); 13C NMR
;
δ 2.40–2.70 (m, 2H, CH2CO2H), 3.47–3.58 (m, 2H, H-4 + H-5), (100 MHz, D2O) δ 34.4 (CH2CO2H), 47.8 (C-1′), 55.9 (C-2), 61.6
3.68 (br d, J = 12.0 Hz, 1H, H-5), 3.82 (br s, 2H, H-3 + H-4), 4.12 (C-5), 69.1 (C-3), 72.6 (C-4), 128.7, 130.7 (CH–Ph), 130.5, 134.1
(d, J = 13.2 Hz, 1H, H-1′), 4.24 (d, J = 13.2 Hz, 1H, H-1′), 5.93 (s, (C-q), 177.4 (CvO). HRMS (ESI): calcd for C13H17ClNO4:
1H, H-8′), 5.94 (s, 1H, H-8′), 6.85–6.94 (m, 3H, H–Ph); 13C NMR 286.0846 (M + H+); found: 286.0851.
(100 MHz, D2O) δ 35.5 (CH2CO2H), 48.8 (C-1′), 55.5 (C-2), 61.7
5.2. Trifluoroacetic acid
(C-5), 69.6 (C-3), 72.7 (C-4), 100.9 (C-8′), 108.3, 109.1, 122.9
(CH–Ph), 127.2, 146.9, 147.1 (C-q), 178.1 (CvO). HRMS (ESI):
calcd for C14H20NO7: 314.1234 (M + H2O + H+); found: acid: (3aR,6R,6aS)-4-benzyl-6-hydroxyhexahydro-2H-furo[3,2-b]
314.1233. pyrrol-2-one (13a) and 2-((2R,3S,4R)-1-benzyl-3,4-dihydroxypyr-
5.2.1. Formation of a mixture of salts of trifluoroacetic
5.1.4. Synthesis of 2-((2S,3S,4R)-N-(4-fluorobenzyl)-3,4- rolidin-2-yl) acetic acid (8a). To a solution of β-aminoester 6a
dihydroxypyrrolidin-2-yl)acetic acid (8c). (i) β-Aminoester 6c (30 mg; 0.08 mmol) in 1,4-dioxane (1.62 mL) was added tri-
(60 mg, 0.15 mmol); solvent: 1,4-dioxane (2 mL); HCl 37% fluoroacetic acid until a 6 M acid solution was formed
This journal is © The Royal Society of Chemistry 2019
Org. Biomol. Chem., 2019, 17, 10052–10064 | 10061